Current topics on plasma lipoprotein, phospholipase A2, and leptin receptor of aquatic animals
نویسندگان
چکیده
منابع مشابه
current concepts on anti-phospholipase a2 receptor antibody in idiopathic membranous nephropathy.
letter to the editor
متن کاملVariability of lipoprotein-associated phospholipase A2 measurements.
We read with interest the recent report in this journal by Khuseyinova and colleagues regarding the variability of serial lipoprotein-associated phospholipase A2 (Lp-PLA2) measurements in postmyocardial infarction patients (1). Because Lp-PLA2 plays a role in inflammation but, unlike other inflammatory proteins , is not an acute-phase reactant (2), nonspecificity issues associated with acute-ph...
متن کاملLipoprotein-associated Phospholipase A2: Effects of Low Density Lipoprotein Apheresis
In addition to hypercholesterolemia, chronic arterial inflammation has been shown to be strongly associated with atherosclerosis and cardiovascular disease (CVD) [1]. The accumulation and oxidation of LDL within the intima trigger inflammatory processes within the vessel wall. Certain markers of inflammation, such as C-reactive protein (CRP), soluble CD40 ligand (sCD40L), oxidized LDL, and lipo...
متن کاملEffect of Cardiovascular Drugs on the Plasma Levels of Lipoprotein- Associated Phospholipase A2 (Lp-PLA2)
Several lines of evidence suggest that the lipoprotein-associated phospholipase A2 (Lp-PLA2) plays an important role in the pathogenesis of atherosclerotic disease. From a pathophysiological point of view the enzyme bound to apolipoprotein-B-containing lipoproteins (which corresponds to more than 90% of plasma enzymatic activity) may play a proatherogenic role since it generates lysophosphatidy...
متن کاملDifferential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2.
OBJECTIVE Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a predictor for incident atherosclerotic disease. We investigated the effect of 3 hypolipidemic drugs that exert their action through different mechanisms on plasma and lipoprotein-associated Lp-PLA2 activity and mass. METHODS AND RESULTS In 50 patients with Type IIA dyslipidemia were administered rosuvastatin (10 mg daily), where...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: NIPPON SUISAN GAKKAISHI
سال: 2004
ISSN: 0021-5392,1349-998X
DOI: 10.2331/suisan.70.764